Product Information
1V209 is a vaccine adjuvant that has been shown to stimulate an antitumor response. It is a molecule that binds to toll-like receptor 4 (TLR4) on tumor cells, stimulating TLR4-mediated signaling pathways, which induces the production of death proteins. 1V209 also upregulates PD-L1 expression in tumor cells and activates the immune system to target and kill cancer cells. 1V209 may be used as a cancer therapy or as a vaccine adjuvant against infectious diseases such as hepatitis B, hepatitis C, and human immunodeficiency virus.
Chemical properties
Technical inquiry about: 3D-MSB44454 1V209
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
